Benzinga | Nov 2, 2021 05:11PM EDT

Pulmonx Q3 EPS $(0.28) Beats $(0.37) Estimate, Sales $13.30M Beat $13.18M Estimate

Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.37) by 24.32 percent. This is a 79.56 percent increase over losses of $(1.37) per share from the same period last year. The company reported quarterly sales of $13.30 million which beat the analyst consensus estimate of $13.18 million by 0.91 percent. This is a 25.33 percent increase over sales of $10.61 million the same period last year.